β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure
- 1 November 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 358 (9293), 1609-1610
- https://doi.org/10.1016/s0140-6736(01)06660-0
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Is the optimal dose of angiotensin-converting enzyme inhibitors in patients with congestive heart failure definitely established?∗∗Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.Journal of the American College of Cardiology, 2000
- Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failurePublished by Oxford University Press (OUP) ,2000
- Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart FailureCirculation, 1999
- Benefit of β-blockers for heart failure: proven in 1999The Lancet, 1999
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972